Efficacy of tirzepatide versus SGLT2 inhibitors in metabolic dysfunction-associated steatotic liver disease (MASLD): a multicenter propensity-matched real-world study

Hepatology International · Published 2026-07-03 · DOI 10.1007/s12072-026-11122-3

Authors (9)

Ibrahim Khalil, Pallab Sarker, Nabila Nur, Md. Imran Hossain, Aizaz Anwar Khalid, Sajjad Ghanim Al-Badri, Mst. Mahmuda Akter, Manisha Das, Mohd Turzo Rahman

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Khalil, I., Sarker, P., Nur, N., et al. (2026). Efficacy of tirzepatide versus SGLT2 inhibitors in metabolic dysfunction-associated steatotic liver disease (MASLD): a multicenter propensity-matched real-world study. Hepatology International. https://doi.org/10.1007/s12072-026-11122-3

Related articles